SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

Shanton Pharma Receives EMA and FDA Pediatric Study Waivers for SAP-001

The waivers mean pediatric clinical studies of SAP-001 in hyperuricemia and gout are not needed.

Related stories